Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
cameron.bissett@linacre.ox.ac.uk

Research groups

Oxford Vaccine Group

Cameron Bissett

Research Assistant

Recent publications

Heterologous mucosal vaccine boosting enhances mucosal and systemic immunity by distinct mechanisms.

Bissett C. et al, (2026), J Exp Med, 223

The systemic-prime, mucosal-boost vaccine regimen for protection against respiratory viruses

Bissett C., (2025)

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 Beta (B.1.351) and other variants of concern in preclinical studies

Spencer AJ. et al, (2021)

Heterologous vaccination regimens with self-amplifying RNA and Adenoviral COVID vaccines induce robust immune responses in mice

Spencer AJ. et al, (2021)

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.

van Doremalen N. et al, (2020), Nature, 586, 578 - 582

More publications